← All themes

Genomics & Gene Editing

Genomics reads the genetic code and gene editing rewrites it, which can turn an inherited disease from a lifelong condition into a single treatment. Sequencing cost has fallen far enough to make study at population scale routine.

199 stocks

Gene Therapy

#	Name	Funds holding	Growth	Growth %	Fund value
51	BLCM 51 DELISTED Bellicum Pharmaceuticals, Inc. BLCM	79	-15	-16%	$42M
52	52 Krystal Biotech KRYS $9.49B	76	+19	+33%	$397M
53	PTE 53 DELISTED PolarityTE, Inc. Common Stock PTE	74	+3	+4%	$61.2M
54	54 Solid Biosciences SLDB $608M	74	0	0%	$128M
55	55 DELISTED BioLife Solutions BLFS	73	+7	+11%	$150M
56	56 ARK Genomic Revolution ETF ARKG $2B	72	+8	+13%	$105M
57	57 Cellectis CLLS $107M	70	+7	+11%	$210M
58	58 Marker Therapeutics MRKR $18M	70	+14	+25%	$134M
59	RUBY 59 DELISTED Rubius Therapeutics, Inc RUBY	69	+2	+3%	$1.23B
60	60 MeiraGTx Holdings MGTX $909M	68	+13	+24%	$335M
61	ORTX 61 DELISTED Orchard Therapeutics plc American Depositary Shares ORTX	68	+25	+58%	$848M
62	62 Personalis PSNL $1.69B	68	+68	–	$403M
63	63 Precision BioSciences DTIL $165M	63	+13	+26%	$291M
64	64 Arbutus Biopharma ABUS $842M	62	-10	-14%	$44M
65	65 BridgeBio Pharma BBIO $12.9B	61	+61	–	$2.7B
66	ADAP 66 DELISTED Adaptimmune Therapeutics ADAP	59	-9	-13%	$274M
67	67 Mustang Bio MBIO $2.92M	55	+18	+49%	$40.1M
68	68 ProQR Therapeutics PRQR $198M	55	-1	-2%	$215M
69	69 Cibus CBUS $100M	52	+5	+11%	$115M
70	ISEE 70 DELISTED IVERIC bio, Inc. Common Stock ISEE	52	-6	-10%	$21.2M
71	71 Fortress Biotech FBIO $62.7M	49	0	0%	$9.37M
72	72 Adicet Bio ACET $45.3M	48	-1	-2%	$190M
73	73 Stoke Therapeutics STOK $1.56B	47	+47	–	$409M
74	AGTC 74 DELISTED Applied Genetic Technologies Corporation AGTC	46	-4	-8%	$25.9M
75	75 Autolus Therapeutics AUTL $439M	46	+11	+31%	$344M